TAMI WIELAND: Open Payments
NPI 1417123399 · LA VERNIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,650 in 96 payments from 15 companies in 2025. Trend: 2023 $1,113 · 2024 $1,685 · 2025 $1,650
Food & beverage: $1,650
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $340 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $311 |
| Novo Nordisk Inc | 13 | $192 |
| PFIZER INC. | 12 | $156 |
| AstraZeneca Pharmaceuticals LP | 5 | $152 |
| Amgen Inc. | 11 | $140 |
| TOLMAR, INC. | 4 | $68 |
| Alnylam Pharmaceuticals Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $53 |
| Axsome Therapeutics, Inc. | 3 | $52 |
Products named: Kerendia, VRAYLAR, NURTEC ODT, AIRSUPRA, Wegovy, UBRELVY, OTEZLA, REPATHA.
Industry payments across TX — which companies pay providers there.
